title: Determination of mirtazapine in spiked human plasma and tablets by first derivative spectrofluorimetric method.
abstract: A sensitive first derivative spectrofluorimetric method ((1)D-spectrofluorimetry) was developed for the determination of mirtazapine. Calibration graph for mirtazapine determination was established using the first derivative amplitudes of the mirtazapine emission spectrum (λ ex = 314 nm) in 0.1 M sulphuric acid measured at 375-435 nm from peak to peak, as the analytical signals. Moreover, the ratio of (1)D-spectrophotometric peak amplitudes at these wavelengths was calculated and used for the detection of the presence of interferences. Linearity range was found to be between 1 and 40 ng ml(-1) with correlation coefficient (r) = 0.9999. The limit of quantitation (LOQ) was 1.0 ng ml(-1) and the limit of detection (LOD) was 0.2 ng ml(-1). The proposed method was validated according to ICH; and it has been applied for the drug determination in human plasma without prior extraction and in tablets. The proposed method's accuracy, reproducibility, selectivity and simplicity suggest its application in quality control analysis of the drug.
authors: Faculty of Pharmacy, Department of Pharmaceutical Analytical Chemistry, University of Alexandria, El-Messalah, Alexandria 21521, Egypt.
authors: Rasha M
authors: RM
authors: Youssef
keywords: 1D-spectrofluorimetry; Mirtazapine; Spiked human plasma; Tablets
references: Electrophoresis. 2007 Aug;28(15):2717-25
references: 17592613
references: J Pharm Biomed Anal. 1994 Mar;12(3):383-7
references: 8031939
references: Anal Chim Acta. 2007 May 22;591(2):141-7
references: 17481400
references: Anal Chim Acta. 2008 Jan 7;606(1):80-91
references: 18068774
references: J Pharm Biomed Anal. 2002 Apr 15;28(2):365-71
references: 11929680
references: J Pharm Biomed Anal. 2002 Jan 1;27(1-2):9-18
references: 11682205
references: J Clin Psychiatry. 2005 Apr;66(4):515-20
references: 15816795
references: J Clin Psychiatry. 1999 Jul;60(7):446-8
references: 10453798
references: Hum Psychopharmacol. 2006 Mar;21(2):117-25
references: 16342227
references: Forensic Sci Int. 2005 Dec 20;155(2-3):193-204
references: 16226158
references: J Pharm Biomed Anal. 1997 Nov;16(3):431-8
references: 9589401
references: J Pharm Biomed Anal. 2000 Dec;24(1):11-7
references: 11108534
references: J Psychopharmacol. 2005 Nov;19(6):567-96
references: 16272179
references: Eur J Cancer Care (Engl). 2007 Jul;16(4):351-4
references: 17587360